PTC299 Terminated Phase 2 Trials for Neurofibromatosis, type 2 (acoustic neurofibromatosis) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00911248 | PTC299 for Treatment of Neurofibromatosis Type 2 |